Filing Details
- Accession Number:
- 0000849146-22-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-09 16:05:53
- Reporting Period:
- 2022-02-07
- Accepted Time:
- 2022-02-09 16:05:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 849146 | Lifevantage Corp | LFVN | Pharmaceutical Preparations (2834) | 841097796 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1309611 | A Michael Beindorff | 3300 Triumph Blvd, Suite 700 Lehi UT 84043 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-07 | 7,193 | $4.85 | 84,312 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person's purchase of 7,143 of the shares of common stock of LifeVantage Corporation (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 against sales by the Reporting Person of the Issuer's common stock on December 7, 2021 and December 8, 2021. The Reporting Person has disgorged $12,661.27 to the Issuer, representing the full amount of the deemed profit realized in connection with the short swing transaction.
Billionaire Hedge Funds
